Stay updated on Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.

Latest updates to the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page
- ChecktodayChange DetectedThis update corresponds to the study’s **results being posted (2026-04-24)** and revises/defines key **outcome measure details**—notably the timing and definitions of endpoints such as **time to hospital readmission or death (all-cause and respiratory-cause)**, **treatment failure**, and counts of hospital readmissions and exacerbations over the **48-week** period. It also updates the specification of several measured patient outcomes (e.g., questionnaire-based health status scales such as eMRC/WEMWBS/SPPB/LCADL, oxygen/inflammatory marker outcomes, and continuous measures including temperature and heart rate across the follow-up window).SummaryDifference5%

- Check8 days agoChange DetectedRevision updated from v3.0.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the Study Plan.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This change affects only the revision metadata, not the study details or user actions.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.1 updated from v3.4.0; this appears to be a backend/UI metadata update with no changes to study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.